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Carcinoma of the external auditory canal (EAC) is a rare tumor and little information is available 
regarding parotid gland in surgically treating EAC carcinomas. This study aimed to investigate the 
mode of parotid involvement in EAC carcinoma through staging and histopathological analysis, and 
to establish surgical guidelines for the parotid gland management when there is no clinical evidence of 
parotid involvement. Sixty-five patients with EAC carcinoma who underwent temporal bone resection 
and any type of parotidectomy simultaneously were retrospectively reviewed. The rate of direct parotid 
invasion and parotid nodal involvement was analyzed according to the stage and histopathological 
findings. Among the 65 patients, 39 were confirmed to have squamous cell carcinoma (SCC) and 26 were 
confirmed to have adenoid cystic carcinoma (ACC). Direct parotid invasion occurred in 7 of 39 patients 
with SCC, only in the advanced stages, and in 15 of 26 patients with ACC, regardless of stage. Metastasis 
to the parotid node was noted in 6 patients with advanced-stage SCC, whereas no patient with ACC 
showed parotid nodal metastasis. For adequate tumor control with low risk of surgical complications, 
evidence based tailored parotidectomy should be applied. With no evidence of parotid involvement, an 
elective parotidectomy can be excluded in early SCC, whereas a total parotidectomy is recommended 
for advanced SCC. In ACC, basal resection of the parotid gland rather than a superficial or total 
parotidectomy should be performed at all disease stages.
Carcinoma of the external auditory canal (EAC) is extremely rare, with an annual incidence of 1 per 1 million 
population1, and it can be life threatening without early aggressive treatment2. Various treatments have been con-
sidered and studied, and en bloc resection of the tumor with an adequate safe margin remains the basic and most 
important principle3,4. However, deciding the extent of resection is problematic, because minimal interventions 
threaten oncologic safety and aggressive surgical intervention is associated with a higher rate of complications5.
Parotidectomy is another concern. Tumors arising from the temporal bone often directly invade the parotid 
gland through the Santorini fissure or the foramen of Huschke6. Furthermore, the parotid gland contains the first 
lymph nodes drained from the EAC that may indicate that either the parotid gland or the parotid node could be 
involved in EAC carcinoma7. Owing to the rarity of EAC carcinoma, the available literature reports do not pro-
vide sufficient information about the mode of parotid involvement in this cancer. There should be no hesitation 
in performing a therapeutic parotidectomy when parotid involvement is apparent, but performing an elective 
parotidectomy with no clinical evidence of parotid involvement remains controversial. Some studies reported 
that there was no correlation between performing elective parotidectomy and the patient survival rate1,8, whereas 
others advocate elective parotidectomy in every cases9,10. As parotidectomy has a risk of facial nerve injury and 
could cause cosmetic issues such as asymmetric facial volume after surgery, unnecessary parotidectomy should be 
avoided. However, if parotidectomy is omitted in situations in which it is essential, the possibility for recurrence 
and final mortality highly increases. This dilemma arouses the necessity for proper guidelines for elective parot-
idectomy in the treatment of EAC carcinoma.
This study was performed to provide guidelines for the management of the parotid gland in treating EAC car-
cinoma when there is no clinical evidence of parotid involvement. The rate of direct parotid gland invasion and 
parotid node metastasis in patients with squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) of 
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the EAC was examined according to the postoperative tumor stage. The data include those from a previous report 
from our institute11.
Results
Patient Characteristics. There were 6 stage I patients, 8 stage II patients, 8 stage III patients, and 17 stage IV 
patients in the SCC group. In the ACC group, there were 3 stage I patients, 6 stage II patients, 4 stage III patients, 
and 13 stage IV patients. The surgical procedures performed were as follows: lateral temporal bone resection 
(LTBR) in 35 patients with stage I, II, and III; subtotal temporal bone resection in 29 patients with stage III and 
IV; and total temporal bone resection in 1 patient with stage IV. The details of the patients are listed in Table 1.
Direct Parotid Invasion Pattern. In SCC, direct parotid invasion was noted only in advanced-stage cases 
(two at stage III and five at stage IV). In ACC, direct parotid invasion was more common, and invasion was 
observed even in early-stage cases (two at stage I, three at stage II, two at stage III, and eight at stage IV; Fig. 1). 
Direct parotid invasion in early carcinoma was significantly more common in ACC than in SCC (p = 0.004, 
Table 2). Direct parotid invasion was also more common in advanced SCC than in early SCC (p = 0.036, Table 2).
Parotid Nodal Metastasis Pattern. Seven cases of SCC at an advanced stage (two at stage III and four at 
stage IV) had subclinical parotid nodal metastasis, but none of the patients with ACC had parotid nodal metas-
tasis (Table 3). Although the differences were not significant (p = 0.071 and p = 0.066), probably due to the small 
numbers of patients, parotid node metastasis was more common in advanced SCC than in early or advanced 
ACC.
Discussion
Primary malignant tumors of the EAC are rare, with an incidence of <1 per 1 million population per year1. SCC 
is the most common type of EAC carcinoma, accounting for 80% of EAC tumors, whereas ACC accounts for 
5% as the second most common type12. SCC and ACC have their own characteristics; but owing to the rarity 
of EAC carcinoma, their characteristic differences in this cancer are not clearly specified. In this study, we per-
formed a retrospective review of surgical specimens, and we found that direct parotid invasion occurred only in 
advanced-staged SCC, whereas ACC showed direct parotid invasion both in the early and advanced stages. SCC 
is known to involve both the cartilaginous and bony parts of the EAC, whereas ACC tends to involve only the 
cartilaginous part in the early stage13. The Santorini fissure, a potent outlet to the parotid gland, is located at the 
anterior part of the cartilage of the EAC. The tendency of ACC to grow on the superficial part of the EAC and the 
anatomical position of the Santorini fissure may explain the frequent direct invasion of ACC to the parotid gland 
even in the early stage. Huschke’s foramen is another outlet to the parotid gland and located at the floor of the 
bony part of the EAC. Since it is normally closed in adults14, it could be ignored in the general population. In case 
of SCC, the carcinoma is completely confined to the bony tube and thus is relatively not capable of invading the 
parotid gland directly. However, the growth pattern in the advanced stage, such as bony structure or soft tissue 
invasion, showed no significant difference between the two histopathologies13.
The parotid gland area is abundantly supplied by various nearby lymph nodes, with the lymphatic drainage 
from the facial skin and scalp being the most representative. The EAC skin also has a lymphatic drainage to the 
parotid gland. While most external ear carcinomas show parotid node involvement, EAC carcinoma involves 
only the parotid node when it is extensive and in the advanced stages15,16. The causes for this difference are not 
well known, but Choi et al. suggested that the lymphatic network of the EAC might be less developed than that in 
the external ear11. Our study revealed node involvement in only advanced-stage SCC cases, as shown in previous 
reports. ACC showed no nodal involvement in all stages in our study, and this result was also identical to the 
report by Xia et al.13. The cause of the difference is thought to be the histopathologic characteristics. The charac-
teristics of ACC of the EAC are known to be as same as those encountered in small salivary gland ACC, including 
silent growth, local recurrence, perineural invasion rather than nodal involvement, and late distal metastasis, 
mostly to the lung, even in the early stages17.
Although all patients in our study received parotidectomy, either therapeutic or elective, treatment failure 
such as tumor recurrence or distant metastasis also occurred. However, it cannot be concluded that parotidec-
tomy is not necessary. Ihler et al. studied 36 patients with EAC carcinoma and reported that the patients without 
parotidectomy showed a mean survival time below the average of the total group3. Leong et al. studied 35 patients 
with SCC of the EAC8, and although parotidectomy was not statistically considered a prognostic factor in their 
report, they recommended elective parotidectomy for all T3 and T4 cancers for best practice. Also, Zhang et al. 
suggested that superficial parotidectomy is necessary for patients with early-stage EAC carcinoma, as well as for 
those with advanced stages4. Parotidectomy is undoubtedly required in the surgical treatment of EAC carcinoma 
in some patients, but the proper extension of parotidectomy is still controversial. Moreover, although the com-
plication rates after parotidectomy are not very high18, critical complications such as facial nerve injury, first bite 
syndrome, Frey syndrome, or facial asymmetry definitely lower the quality of life19–21.
Our data indicated that elective total parotidectomy to secure an adequate safety margin and to control 
occult parotid node metastasis is mandatory for advanced-stage SCC, even when there is no clinical evidence 
for parotid involvement. However, in terms of the characteristics and mode of parotid involvement in ACC, 
elective total parotidectomy is somehow an excessive treatment for this tumor. Instead, partial resection of the 
basal (postero-superior) part of parotid gland can provide an adequate safety margin in treating ACC, which can 
be easily applied while performing temporal bone resection (Fig. 2). Simple resection of the gland abutting the 
ear canal that lies posterior to the upper branch of the facial nerve could achieve oncological benefits in ACC. 
This partial basal resection strategy is free from additional incision lines and critical complications after parot-
idectomy, as described above. The operation time is also reduced. Nevertheless, a demarcation of the facial nerve 
www.nature.com/scientificreports/
3SCIentIfIC REPORTS |  (2018) 8:12112  | DOI:10.1038/s41598-018-30536-0
Patient No. Sex/Age (Years) Preoperative Stage Surgery Parotidectomy Neck Dissection
Patients with Squamous Cell Carcinoma
1 F/68 I LTBR Superficial None
2 M/73 I LTBR Total Lv. I, II, III, IV, V
3 M/79 I LTBR Superficial None
4 M/60 I LTBR Total Lv. I, II, III
5 M/37 I LTBR Superficial None
6 M/64 I LTBR Total Lv. I, II, III
7 M/34 II LTBR Superficial None
8 F/41 II LTBR Superficial None
9 F/79 II LTBR Superficial None
10 F/64 II LTBR Superficial Lv. II
11 F/52 II LTBR Superficial None
12 M/67 II LTBR Superficial None
13 F/67 II LTBR Superficial None
14 F/60 II LTBR Superficial None
15 M/70 III LTBR Superficial None
16 M/68 III LTBR Partial None
17 M/66 III LTBR Superficial None
18 F/65 III STBR Total Lv. II
19 M/60 III STBR Total Lv. II
20 M/57 III STBR Total None
21 F/64 III STBR Total Undescribed
22 F/49 III STBR Total Undescribed
23 F/49 IV LTBR Partial None
24 F/72 IV LTBR Superficial None
25 M/48 IV LTBR Total Lv. III
26 F/54 IV LTBR Superficial None
27 M/70 IV LTBR Superficial Lv. II, III
28 M/43 IV LTBR, auricle resection Total Lv. I, II, III, IV, V
29 F/76 IV STBR Superficial None
30 M/52 IV STBR Total None
31 M/47 IV STBR Total Lv. I
32 F/55 IV STBR Total Lv. IV
33 F/44 IV STBR Total None
34 M/45 IV STBR Total Lv. II
35 M/58 IV STBR Superficial Lv. I, II, III
36 M/56 IV STBR Total Undescribed
37 M/62 IV STBR Total Undescribed
38 M/48 IV STBR Total Undescribed
39 M/35 IV TTBR Total Lv. I, II, III
Patients with Adenoid Cystic Carcinoma
1 M/57 I LTBR Total None
2 F/47 I LTBR Superficial None
3 F/49 I LTBR Superficial None
4 M/66 II LTBR Superficial None
5 F/44 II LTBR Superficial None
6 F/38 II LTBR Superficial None
7 F/71 II LTBR Superficial None
8 M/52 II STBR Superficial None
9 F/50 II STBR Superficial None
10 F/48 III LTBR Superficial None
11 F/47 III LTBR Superficial None
12 F/29 III LTBR Superficial None
13 F/60 III STBR Total Undescribed
14 M/50 III STBR Total Undescribed
15 F/53 IV LTBR Total None
Continued
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to a certain degree is also required in partial resection. The known factors associated with a higher incidence of 
facial nerve deficit include the extent of surgery and the stretching and sectioning of facial nerve branches during 
surgery22. It can be interpreted that manipulating the facial nerve causes facial nerve deficit. The suggested partial 
basal resection strategy requires a demarcation of the facial nerve without the need for manipulating it; therefore, 
safer outcomes are expected. The extent of resection should be considered. If parotid infiltration is not detected 
in preoperative imaging evaluations, considering their detectable limitations, we suggest that the proper surgical 
margin should be about 1 cm.
Patient No. Sex/Age (Years) Preoperative Stage Surgery Parotidectomy Neck Dissection
16 M/51 IV LTBR Total None
17 F/54 IV STBR Superficial Lv. II
18 F/49 IV STBR Superficial None
19 F/67 IV STBR Superficial Lv. II
20 F/47 IV STBR Total None
21 M/45 IV STBR Total None
22 M/26 IV STBR Total None
23 M/33 IV STBR Total None
24 F/60 IV STBR Total Undescribed
25 F/67 IV STBR Total Undescribed
26 F/53 IV STBR Total Undescribed
Table 1. Characteristics of the Patients. LTBR = lateral temporal bone resection; STBR = subtotal temporal 
bone resection; TTBR = total temporal bone resection; Lv. = level.
Figure 1. Parotid involvement in adenoid cystic carcinoma. (A) Magnetic resonance image demonstrating the 
findings of external auditory canal (EAC) carcinomas (white arrows). The tumor is confined in the EAC without 
parotid involvement. (B) Histopathologic specimen from the same patients. The tumor is directly extending through 
the cartilage and an invading lesion in the parotid gland (black arrow head) is shown (magnification, x100).
Stage
Squamous Cell Carcinoma Adenoid Cystic Carcinoma
P-valuePatients (n) Direct Invasion (%) Patients (n) Direct Invasion (%)
Early-stage
I 6 0 (0%) 3 2 (67%)
0.004
II 8 0 (0%) 6 3 (50%)
Advanced-stage
III 8 2 (25%) 4 2 (50%)
0.061
IV 17 5 (29%) 13 8 (62%)
P-value 0.036 1.000
Table 2. Pattern of Parotid Involvement in External Auditory Canal Carcinoma According to Stage and 
Pathology.
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Perineural invasion should be considered in treating ACC of the EAC carcinoma because it is a common 
histological finding in ACC and is a possible route for tumor cell dissemination23. However, the presence of peri-
neural invasion is known to be an adverse prognostic factor only when a major nerve is involved24, which can be 
detected preoperatively. In such cases, radical parotidectomy including the facial nerve is essential for oncological 
safety and reducing mortality. Otherwise, if a major nerve is not involved, there is no evidence that partial resec-
tion of the parotid gland rather than parotidectomy increases the rate of perineural invasion. Parotidectomy need 
not be performed to control preoperatively undetected perineural invasion, and a partial resection of the parotid 
gland is thought to be a sufficient treatment for EAC carcinoma with ACC. For suspected microscopic perineural 
invasion, postoperative radiation could be applied.
For adequate tumor control with low risk of surgical complications, evidence based tailored parotidectomy 
should be applied. A therapeutic parotidectomy must be performed when there is clinical evidence of parotid 
involvement. However, with no evidence of parotid involvement, an elective parotidectomy can be excluded in 
early SCC, whereas a total parotidectomy is recommended for advanced SCC. In ACC, basal resection of the 
Stage
Squamous Cell Carcinoma Adenoid Cystic Carcinoma
P-valuePatients (n) Node Metastasis (%) Patients (n) Node Metastasis (%)
Early-stage
I 6 0 (0%) 3 0 (0%)
1.000
II 8 0 (0%) 6 0 (0%)
Advanced-stage
III 8 2 (25%) 4 0 (0%)
0.066
IV 17 4 (24%) 13 0 (0%)
P-value 0.071 1.000
Table 3. Pattern of Node Metastasis in External Auditory Canal Carcinoma According to Stage and Pathology.
Figure 2. Schematic drawing of the suggested partial basal resection of the parotid gland during temporal 
bone resection in treating adenoid cystic carcinoma. (A) Removal of the bone from 360° around the canal and 
isolation of the ear canal as an en bloc specimen. (B) Resection of the gland abutting the ear canal to include 
it in the specimen. (C) Lateral temporal bone resection with a partial basal resection of the parotid gland in 
continuity with the ear canal.
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parotid gland rather than a superficial or total parotidectomy should be performed at all disease stages. Since 
treatment is predicated on the underlying pathology and tumor extent as defined by imaging studies, a prudent 
preoperative evaluation is essential.
There is a critical limitation to the suggested strategy from actual applications. Practical data or supporting ref-
erences are hardly available. Tumor control results from none, partial and total resection of parotid gland in treat-
ing early-stage ACC should be compared to prove the oncological safety and the benefits. To our knowledge, one 
paper compares the surgical outcomes of early ACC using different surgical procedures. In that study, eight patients 
underwent LTBR only and nine underwent LTBR including superficial parotidectomy. The 5-year survival rate for 
the LTBR-only group was 75%, whereas the LTBR plus superficial parotidectomy group had a 100% survival rate. 
The results underscore the reliability of the suggested strategy. Nevertheless, multicenter retrospective chart reviews or 
meta-analyses of EAC carcinoma with various parotidectomy procedures are required to strengthen our conclusions.
Methods
Patients. The study included 65 patients (31 males, 34 females; mean age, 55 years; age range, 26–79 years) 
with primary EAC carcinoma, undergoing parotidectomy with various types of temporal bone resection between 
August 1989 and October 2015 at the Department of Otorhinolaryngology, Yonsei University. Histopathological 
examination confirmed 39 cases of SCC and 26 cases of ACC. The cancer stages were determined preoperatively 
through radiographic evaluations such as computed tomography and magnetic resonance imaging, and postop-
eratively with pathologic confirmation according to the modified Pittsburgh tumor staging system15. Preoperative 
images were interpreted by blinded two neuroradiologists with special regard to the origin of the carcinoma. A 
retrospective review of the surgical specimens was performed with specific reference to parotid node metastasis 
and parotid invasion according to the tumor stage and pathology.
All procedures were in accordance with the Declaration of Helsinki of 1975. The study was approved by the 
IRB of Severance Hospital, Seoul, Korea (4-2018-0060).
Treatment. Surgery was carried out as an initial treatment in all patients. The procedures have been described 
in detail by Gacek and Goodman7. Postoperative radiation, adjuvant chemotherapy, or concurrent chemoradia-
tion was applied on the basis of pathologic stage, surgical margin status, or the presence of perineural invasion in 
some advanced-staged cases. All patients in our study underwent therapeutic or elective parotidectomy involving 
partial, superficial, or total resection.
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